Key result
Kidney transplantation improved the renin/Angiotensin II correlation in non-ACEi-treated patients from R²=0.660 on hemodialysis to R²=0.918 post-transplant.
Why the study?
Does successful kidney transplantation restore physiological molecular regulation of the classical and alternative renin-angiotensin system in maintenance hemodialysis patients?
Cohort (n=12)
No
Does successful kidney transplantation restore physiological molecular regulation of the classical and alternative renin-angiotensin system in maintenance hemodialysis patients?
Answers are grounded in this paper and cite their sources.
Successful kidney transplantation restores physiological renin-dependent Angiotensin II formation in non-ACE inhibitor-treated patients, though persistent inter-individual variability and low alternative RAS peptide levels highlight the need for individualized post-transplant antihypertensive therapy.
Objective: We aimed at assessing the molecular adaptation of the renin-angiotensin system (RAS) after successful kidney transplantation (KTX). Materials and methods: In this prospective, exploratory study we analyzed 12 hemodialysis (HD) patients, who received a KTX and had excellent graft function six to 12 months thereafter. The concentrations of plasma Angiotensin (Ang) peptides (Ang I, Ang II, Ang-(1–7), Ang-(1–5), Ang-(2–8), Ang-(3–8)) were simultaneously quantified with a novel mass spectrometry-based method. Further, renin and aldosterone concentrations were determined by standard immunoassays. Results: Ang values showed a strong inter-individual variability among HD patients. Yet, despite a continued broad dispersion of Ang values after KTX, a substantial improvement of the renin/Ang II correlation was observed in patients without RAS blockade or on angiotensin receptor blocker (HD: renin/Ang II R 2 = 0.660, KTX: renin/Ang II R 2 = 0.918). Ang-(1–7) representing the alternative RAS axis was only marginally detectable both on HD and after KTX. Conclusions: Following KTX, renin-dependent Ang II formation adapts in non-ACE inhibitor-treated patients. Thus, a largely normal RAS regulation is reconstituted after successful KTX. However, individual Ang concentration variations and a lack of potentially beneficial alternative peptides after KTX call for individualized treatment. The long-term post-transplant RAS regulation remains to be determined.
No takes yet. Share an insight, caveat, or question.
Antlanger et al. (2017) conducted a cohort in End-stage renal disease on maintenance hemodialysis undergoing kidney transplantation (n=12). Kidney transplantation (KTX) vs. Pre-transplant maintenance hemodialysis (HD) state (intra-individual paired comparison) was evaluated on Correlation between plasma renin and Angiotensin II (Ang II) concentrations in non-ACE inhibitor-treated patients (R² = 0.918 post-KTX vs R² = 0.660 on HD, p=<0.001). Kidney transplantation improved the renin/Angiotensin II correlation in non-ACEi-treated patients from R²=0.660 on hemodialysis to R²=0.918 post-transplant.
Synapse has enriched 10 related papers. Consider them for comparative context: